Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States)-Reference-Cited by-同舟云学术

Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States)

Published:1996-11 Issue:6 Volume:7 Page:575-580
ISSN:0957-5243
Container-title:Cancer Causes and Control
language:en
Short-container-title:Cancer Causes Control

Author:

Green Pamela K.,Weiss Noel S.,McKnight Barbara,Voigt Lynda F.,Beresford Shirley A. A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00051699.pdf

Reference22 articles.

1. Mishell, DR. Estrogen replacement therapy: an overview. Am J Obstet Gynecol 1989; 161: 1825?7.

2. Smith, DC, Prentice, R, Thompson, DJ, et al. Association of exogenous estrogen and endometrial carcinoma, New Engl J Med 1975; 293: 1164?7.

3. Ziel, HK, Finkle, WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. New Engl J Med 1975; 293: 1167?70.

4. Voigt, LF, Weiss, NS. Epidemiology of endometrial cancer. In: Surwit, E, Alberts, D, eds. Endometrial Cancer. Boston, MA (USA): Kluwer Academic, 1989: 1?21.

5. Voigt, LF, Weiss, NS, Chu, J, Daling, JR, McKnight, B, van Belle, G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991; 338: 274?7.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone-Responsive Cancers;Yen and Jaffe's Reproductive Endocrinology;2019

2. Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences;Advances in Experimental Medicine and Biology;2016-12-02

3. For drug-induced carcinogenesis, the observations are the hypothesis;Annals of Epidemiology;2016-11

4. Menopausal hormone therapy and risk of endometrial cancer;The Journal of Steroid Biochemistry and Molecular Biology;2014-07

5. Hormone Responsive Cancers;Yen & Jaffe's Reproductive Endocrinology;2014